Sectors › Healthcare & Life Sciences › Revenue cycle & healthcare admin
Revenue cycle & healthcare admin funding
Revenue cycle & healthcare admin
A sub-sector of Healthcare & Life Sciences. Each company counts once, in its main sub-sector.
208 rounds, $4.3B raised by 163 companies, Jan 2, 2023 to Nov 14, 2026, 9% of Healthcare & Life Sciences capital. Top three companies: Judi Health 10%, Candid Health 5%, ShiftMed 5%.
| Company | HQ | Capital raised | Rounds | Exit |
|---|---|---|---|---|
| Judi Health | United States | $417M | 3 | — |
| Candid Health | United States | $202M | 3 | — |
| ShiftMed | United States | $200M | 1 | — |
| Tennr | United States | $156M | 3 | — |
| Qualified Health | United States | $155M | 2 | — |
| Forus | United States | $150M | 2 | — |
| Commure | United States | $140M | 2 | — |
| AKASA | United States | $120M | 1 | — |
| CodaMetrix | United States | $95M | 2 | — |
| Charta Health | United States | $85M | 3 | — |
| Archy | United States | $85M | 3 | — |
| TJM Labs | United States | $85M | 2 | — |
| Qventus | United States | $85M | 1 | — |
| Latent Health | United States | $80M | 1 | — |
| Nitra | United States | $72M | 2 | — |
| Adonis | United States | $71M | 3 | — |
| Fay | United States | $70M | 2 | — |
| Plenful | United States | $67M | 2 | — |
| Alaffia Health | United States | $65M | 2 | — |
| Healthee | United States | $62M | 2 | — |
| Anterior | United States | $60M | 2 | — |
| Infinitus Systems | United States | $52M | 1 | — |
| Flagler Health | United States | $50M | 1 | — |
| SmarterDx | United States | $50M | 1 | Acquired |
| Cohere Health | United States | $50M | 1 | — |
| Company | Amount | Stage | Announced |
|---|---|---|---|
| Judi Health | $252M | Series F+ | Sep 23, 2025 |
| ShiftMed | $200M | Unlabeled | Feb 6, 2023 |
| Forus | $150M | Series C | Sep 8, 2026 |
| Qualified Health | $125M | Series B | Mar 25, 2026 |
| Candid Health | $120M | Series D | Jul 22, 2026 |
| AKASA | $120M | Series C | Jun 18, 2024 |
| Judi Health | $115M | Series E | Mar 28, 2024 |
| Tennr | $101M | Series C | Jun 18, 2025 |
| Qventus | $85M | Series D | Jan 13, 2025 |
| Latent Health | $80M | Series A | Mar 19, 2026 |